|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||146.20 - 148.70|
|52-week range||119.30 - 202.40|
|Beta (5Y monthly)||1.50|
|PE ratio (TTM)||2.50|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The board of directors for Medicover AB (publ) has today resolved to issue 1,600,000 new class C shares and to immediately thereafter repurchase such 1,600,000 issued class C shares, for the purpose of the long term performance-based share programs for key individuals as approved by the annual general meetings held on 29 April 2021, 27 April 2022 and 27 April 2023 (the "Plan 2021", the "Plan 2022" and the "Plan 2023").
Joe Ryan, CFO, has announced that after 28 years with Medicover he will retire from the company during 2024. Joe Ryan will continue in the role until a successor is in place, ensuring continuity. A search process has started.